AAAAAA

   
Results: 1-3 |
Results: 3

Authors: Nemunaitis, J Khuri, F Ganly, I Arseneau, J Posner, M Vokes, E Kuhn, J McCarty, T Landers, S Blackburn, A Romel, L Randlev, B Kaye, S Kirn, D
Citation: J. Nemunaitis et al., Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer, J CL ONCOL, 19(2), 2001, pp. 289-298

Authors: Nemunaitis, J Ganly, I Khuri, F Arseneau, J Kuhn, J McCarty, T Landers, S Maples, P Romel, L Randlev, B Reid, T Kaye, S Kirn, D
Citation: J. Nemunaitis et al., Selective replication and oncolysis in p53 mutant tumors with ONYX-015, anE1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A Phase II trial, CANCER RES, 60(22), 2000, pp. 6359-6366

Authors: Flood, W Lee, DJ Trotti, A Spencer, S Murphy, B Khuri, F DeConti, R Wheeler, R Forastiere, AA
Citation: W. Flood et al., Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin, SEM RAD ONC, 9(2), 1999, pp. 64-69
Risultati: 1-3 |